bioRxivCancer BiologyPreprint
Mechanistic insights into the interactions between cancer drivers and the tumour immune microenvironment
Abstract
The crosstalk between cancer and the tumour immune microenvironment (TIME) has attracted significant interest because of its impact on cancer evolution and response to treatment. Despite this, cancer-specific tumour-TIME interactions and their mechanisms of action are still poorly understood. Here we identified the interactions between cancer-specific genetic drivers and anti- or pro-tumour TIME features in individual samples of 32 cancer types. The resulting 477 TIME drivers are multifunctional genes whose alterations are selected early in cancer evolution and recur across and within cancer types. Moreover, the anti-tumour TIME driver burden is predictive of overall response to immunotherapy. Focusing on head and neck squamous cancer (HNSC), we rebuilt the functional networks linking specific TIME driver alterations to the TIME state. We showed that TIME driver alterations predict the immune profiles of HNSC molecular subtypes, and that deregulation of keratinization, apoptosis and interferon signalling underpin specific driver-TIME interactions. Overall, our study provides a comprehensive resource of TIME drivers giving mechanistic insights into their immune-regulatory role.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: gene regulatory network inference
- research focus: differential expression
- research focus: cell-cell communication
- approach: statistical model
- approach: machine learning (classical)
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response
M. Pagadala, V. H. Wu, … H. Carter·bioRxiv·Apr 14, 2021
- Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysis
Priyan Bhattacharya, Alban J. Linnenbach, … Rajanikanth Vadigepalli·PLoS Computational BiologyPeer-reviewed·Jun 3, 2025
- Integrative immune subtyping of HNSCC reveals clinically relevant phenotypes and treatment-associated transitions
Indu Khatri, Terezinha Maria de Souza, … Iris C. R. M. Kolder·npj Precision OncologyPeer-reviewed·Apr 23, 2026
- TimiGP-Response: the pan-cancer immune landscape associated with response to immunotherapy
Chenyang Li, Hong Wei, … Chao Cheng·bioRxiv·Jun 21, 2024
- Cancer-specific associations of driver genes with immunotherapy outcome
Tomi Wei Jun, Tao Qing, … Kuan‐lin Huang·bioRxiv·Jun 16, 2020
- Inherited defects in natural killer cells shape tumor immune microenvironment, clinical outcome and immunotherapy response
Xue Xu, Jianqiang Li, … Edwin Wang·bioRxiv·Nov 27, 2018